This further supported the results from previous studies which also confirmed the relationship between the overexpression of DKK1 and the lower overall survival in HNSC (Gao et al., 2018), NSCLC (Yamabuki et al., 2007), and PAAD (Han et al., 2015). This evidence concerns the gene DKK1 and pancreatic adenocarcinoma.